TXCELL develops cell-based immuno-therapies designed for the treatment of severe chronic inflammatory diseases.
Automatic translation

Technologies

  • REDBIOTECH

Activity area

  • HEALTHTECH
  • PHARMATECH
  • CLINIC
  • BIOTECH

Key information

Year of creation

2001

Workforce

11 - 50

Total fundraising amount

12 400 000 €

Last round table level

Contact information

Investment

Total fundraising amount

12 400 000 €

Maximum round table reached

Date Amount Investors Round table
27/11/2012 12 400 000,00 €